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Syncope in Elderly People: A Threatening 
Presentation of Pulmonary Embolism: A Case 
Report
Abstract 
Syncope	 is	a	common	cause	of	hospitalization,	and	 its	 frequency	 increases	with	
age.	Its	prognosis	is	largely	unpredictable,	pending	the	origin	of	the	sudden	loss	of	
consciousness.	We	report	a	case	of	an	old	woman	affected	by	severe	chronic	heart	
failure,	who	died	soon	after	the	development	of	an	episode	of	syncope,	which	was	
eventually	 attributed	 to	 pulmonary	 embolism.	 Anticoagulant	 therapy,	 promptly	
instituted,	 was	 ineffective.	 In	 the	 differential	 diagnoses	 of	 syncope,	 pulmonary	
embolism	should	always	be	considered,	especially	in	old	patients	with	risk	factors	
for	venous	thromboembolism	such	as	a	severe	heart	failure.	In	patients	with	high	
risk	of	death	according	to	the	widely	adopted	risk	stratifications	score,	aggressive	
therapy	 may	 be	 considered	 also	 in	 elderly	 people	 to	 prevent	 unfavourable	
outcomes.	
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Introduction
Syncope	is	defined	as	a	transient	loss	of	consciousness	that	has	
a	 rapid	onset,	 short	duration	and	spontaneous	recovery,	and	 is	
supposedly	due	to	temporary	cerebral	hypoperfusion.	According	
to	 recent	 classifications,	 syncope	 can	 be	 neurally-mediated,	
due	 to	orthostatic	hypotension	or	of	 cardiovascular	origin	 (i.e.,	
arrhythmias, structural cardiovascular diseases or pulmonary 
embolism	[PE])	[1,2].	It	is	a	common	case	of	hospitalization	in	the	
Unites	States.	According	to	the	results	of	a	recent	observational	
cross-sectional	 study,	 the	hospital	mortality	 rate	 for	 syncope	 is	
low	 (0.28%)	 [3].The	 likelihood	 of	 death	 was	 found	 to	 increase	
with	 age,	 becoming	more	 prominent	 after	 the	 age	 of	 40,	 and	
was	found	to	be	associated	with	the	severity	of	the	comorbidity	
index,	the	odds	ratio	(OR)	of	death	being	1.39	(95%	CI,	1.20-1.62)	
in	patients	with	moderate	index,	and	4.14	(95%	CI,	3.05-5.61)	in	
those	with	severe	one	[3].	We	report	a	case	of	an	87	years	woman	
with	chronic	heart	failure,	who	developed	an	orthostatic	syncope	
caused	 by	 pulmonary	 embolism.	 Soon	 after	 recovery	 from	 the	
episode	of	consciousness,	she	was	found	to	be	hemodynamically	
stable.	In	spite	of	prompt	diagnosis,	she	died	few	hours	after	the	
institution	of	full-dose	anticoagulation.
Case Report
An	87	years	old	woman	presented	to	the	Emergency	Department	
of	 the	 University	 Hospital	 of	 Padua	 after	 experiencing	 an	
orthostatic	episode	of	 syncope	associated	with	 vomit.	 She	had	
had	 a	 similar	 episode	 one	month	 earlier,	 which	 had	 remained	
unexplained.	No	fever,	cough,	dyspnoea,	chest	pain,	palpitations	
or	fainting	prior	to	the	event.	
The	patients	had	a	history	of	remote	colon	cancer,	acute	myocardial	
infarction	and	symptomatic	bradycardia	requiring	the	positioning	
of	 an	 indwelling	 pace	 maker.	 Recently,	 she	 had	 suffered	 from	
recurrent	episodes	of	heart	failure	requiring	hospital	admission	
and	diuretic	treatment.	She	had	an	impaired	cognitive	state	and	
a	mild	 renal	 insufficiency.	 The	 patient’s	 supine	 blood	 pressure	
was	 200/95	mmHg,	 heart	 rate	 100	 arrhythmic.	 She	 presented	
pulmonary	 crackles,	 moderate	 mitralic	 systolic	 murmur	 and	
bilateral	 leg	 edema.	 Blood	 tests	 showed	 a	mild	 renal	 and	 liver	
insufficiency,	 normal	 troponin	 I	 level	 and	 remarkably	 elevated	
values	of	pro-BNP	and	D-dimer	value.	Overall,	she	was	regarded	
as	 hemodynamically	 stable.	However,	 the	 simplified	 PESI	 score	
(n=5)	placed	patients	at	a	substantial	risk	for	unfavorable	adverse	
events,	had	a	PE	been	detected	[4].
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pressure	was	high	[4].	Whether	implementing	or	not	aggressive	
(i.e.,	 thrombolytic)	 therapy	 in	patients	with	PE	and	high	 risk	of	
adverse	events	in	spite	of	stable	clinical	condition	is	a	matter	of	
debate,	as	a	recent	major	randomized	clinical	trial	showed	that	the	
benefit/risk	of	such	strategy	may	not	be	favorable,	especially	in	
patients	older	than	75	[5].	However,	physicians	should	be	alerted	
and	consider	this	option	whenever	there	are	not	contraindications	
other	than	elderly	age	to	thrombolysis.	Patients	may	be	offered	
adjusted-dose	 intravenous	 unfractionated	 heparin	 instead	
of	 low-molecular-weight	 heparin	 in	 order	 to	 achieve	 a	 rapid	
anticoagulation,	and	should	be	carefully	monitored,	so	that	the	
decision	whether	continuing	anticoagulation	alone	or	associate	it	
with	a	course	of	a	thrombolytic	therapy	is	timely	taken.
The	 electrocardiography	 revealed	 a	 (previously	 unknown)	
atrial	 fibrillation	 and	 a	well	working	 pace	maker.	 The	 leg	 veins	
ultrasonography	excluded	deep	vein	thrombosis,	the	chest	X-ray	
evidenced	 bilateral	 pleural	 effusion	 and	 an	 enlarged	 heart.	 A	
CT	 pulmonary	 angiography,	 promptly	 performed,	 showed	 a	
thrombotic	 defect	 in	 the	 right	 middle	 lobe	 segmental	 artery	
(Figure 1).
Soon	 after	 diagnosis,	 she	 was	 given	 therapeutic	 doses	 of	 low-
molecular-weight	heparin.	While	on	treatment,	she	had	a	cardiac	
arrest	 few	 hours	 later.	 The	 cardiopulmonary	 resuscitation	 was	
ineffective,	and	she	died.
Discussion
Syncope	 is	 a	 well	 known	 and	 quite	 common	 manifestation	 of	
PE,	 and	 its	 prognosis	 is	 largely	 dependent	 on	 the	 timeliness	
of	 diagnosis	 and	 treatment	 [1,2].	 In	 our	 patients,	 the	 loss	 of	
consciousness	 that	 prompted	 hospital	 admission	 had	 been	
preceded	 by	 a	 similar	 episode	 one	 month	 earlier,	 which	 had	
unfortunately	remained	without	explanations.	
When	the	patient	was	admitted	to	our	department	we	promptly	
suspected	PE	because	of	the	presence	of	a	number	of	well	known	
risk	 factors	 for	 venous	 thromboembolism	 (including	 old	 age,	
chronic	heart	failure	and	poor	mobilization)	and	the	remarkable	
high	values	of	pro-BNP	and	D-dimer.	Our	suspicion	was	confirmed	
by	 a	 CT	 pulmonary	 angiography,	 so	 that	we	 started	 treatment	
with	full	dose	low-molecular	weight	heparin.	In	spite	of	this,	after	
few	hours	she	underwent	a	fatal	cardiac	arrest.	Are	there	lessons	
to	be	learned	from	this	case?	
Syncope	is	a	serious	manifestation	of	PE.	Firstly,	it	places	patients	
at	 risk	of	death	because	of	 the	unpredictable	 consequences	of	
the	 loss	of	 consciousness.	 Secondly,	 it	 generally	 represents	 the	
manifestation	of	either	anatomical	or	clinically	severe	PE.	Indeed,	
the	simplified	PESI	score	(n=5)	qualified	our	patient	as	being	at	
a	 substantial	 risk	 for	unfavorable	outcome,	although	 the	blood	
Figure 1 Coronal	 multiplanar	 reformation	 from	 contrast	
material-enhanced	 pulmonary	 CT	 arteriogram	
shows	 a	 partial	 filling	 defect	 in	 the	 right	 middle	
lobe	segmental	artery	(arrow).	Note	the	associated	
pleural	effusions	(asterisks)	and	enlarged	left	atrium	
(open	arrows).
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